Hybrid biosynthetic gene therapy vector development and dual engineering capacity

Proceedings of the National Academy of Sciences of the United States of America

Volumn 111, Issue 34, 2014, Pages 12360-12365

  Jones, Charles H ^a   Ravikrishnan, Anitha ^a   Chen, Mingfu ^a   Reddinger, Ryan ^b   Ahmadi, Mahmoud Kamal ^a   Rane, Snehal ^a   Hakansson, Anders P ^b   Pfeifer, Blaine A ^a  

^a the State University of New York   (United States)

^b UNIVERSITY AT BUFFALO   (United States)

Author keywords

Bactofection; Cationic polymers; Immunization; Nonviral vectors; Vaccination

Indexed keywords

BACTERIAL VECTOR; OVALBUMIN; DNA VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ARTICLE; BACTERIAL GENE; BIOSYNTHESIS; CONTROLLED STUDY; CROSS PRESENTATION; CYTOTOXICITY; FLOW CYTOMETRY; GENE TARGETING; GENE VECTOR; GENETIC ENGINEERING; GENETIC TRANSFECTION; HYBRID GENE; MOUSE; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; PRIORITY JOURNAL; STOICHIOMETRY; ANIMAL; ANTIGEN PRESENTING CELL; BAGG ALBINO MOUSE; CELL LINE; ESCHERICHIA COLI; FEMALE; GENE THERAPY; GENE TRANSFER; GENETICS; IMMUNIZATION; IMMUNOLOGY; TRENDS;

ANIMALS; ANTIGEN-PRESENTING CELLS; CELL LINE; ESCHERICHIA COLI; FEMALE; GENE TRANSFER TECHNIQUES; GENETIC ENGINEERING; GENETIC THERAPY; GENETIC VECTORS; IMMUNIZATION; MICE; MICE, INBRED BALB C; MODELS, ANIMAL; OVALBUMIN; VACCINES, DNA;

EID: 84906707843     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1411355111     Document Type: Article

References (41)

1. Schmidt C (2013) Vaccines for pandemics. Nat Biotechnol 31(11):957-960.
2. Wirth T, Parker N, Ylä-Herttuala S (2013) History of gene therapy. Gene 525(2):162-169.
3. Leboulch P (2013) Gene therapy: Primed for take-off. Nature 500(7462):280-282.
4. Jones CH, Chen CK, Ravikrishnan A, Rane S, Pfeifer BA (2013) Overcoming nonviral gene delivery barriers: Perspective and future. Mol Pharm 10(11):4082-4098.
5. Pack DW, Hoffman AS, Pun S, Stayton PS (2005) Design and development of polymers for gene delivery. Nat Rev Drug Discov 4(7):581-593. (Pubitemid 40975711)
6. Lynn DM, Langer R (2000) Degradable poly(β-amino esters): Synthesis, characterization, and self-assembly with plasmid DNA. J Am Chem Soc 122(44):10761-10768.
7. Green JJ, Zugates GT, Langer R, Anderson DG (2009) Poly(β-amino esters): Procedures for synthesis and gene delivery. Methods Mol Biol 480:53-63.
8. Sunshine JC, Akanda MI, Li D, Kozielski KL, Green JJ (2011) Effects of base polymer hydrophobicity and end-group modification on polymeric gene delivery. Biomacromolecules 12(10):3592-3600.
9. Sunshine JC, Peng DY, Green JJ (2012) Uptake and transfection with polymeric nanoparticles are dependent on polymer end-group structure, but largely independent of nanoparticle physical and chemical properties. Mol Pharm 9(11):3375-3383.
10. Sunshine JC, Sunshine SB, Bhutto I, Handa JT, Green JJ (2012) Poly(β-amino ester)-nanoparticle mediated transfection of retinal pigment epithelial cells in vitro and in vivo. PLoS ONE 7(5):e37543.
11. Parsa S, Pfeifer B (2007) Engineering bacterial vectors for delivery of genes and proteins to antigen-presenting cells. Mol Pharm 4(1):4- 17.
12. Jones CH, et al. (2013) Polymyxin B treatment improves bactofection efficacy and reduces cytotoxicity. Mol Pharm 10(11):4301-4308.
13. Larsen MD, et al. (2008) Bactofection of lung epithelial cells in vitro and in vivo using a genetically modified Escherichia coli. Gene Ther 15(6):434-442. (Pubitemid 351331001)
14. Castagliuolo I, et al. (2005) Engineered E. coli delivers therapeutic genes to the colonic mucosa. Gene Ther 12(13):1070-1078. (Pubitemid 40946149)
15. Chart H, Smith HR, La Ragione RM, Woodward MJ (2000) An investigation into the pathogenic properties of Escherichia coli strains BLR, BL21, DH5alpha and EQ1. J Appl Microbiol 89(6):1048-1058. (Pubitemid 32055895)
16. Parsa S, Wang Y, Rines K, Pfeifer BA (2008) A high-throughput comparison of recombinant gene expression parameters for E. coli-mediated gene transfer to P388D1 macrophage cells. J Biotechnol 137(1-4):59-64.
17. Critchley RJ, et al. (2004) Potential therapeutic applications of recombinant, invasive E. coli. Gene Ther 11(15):1224-1233. (Pubitemid 39136786)
18. Laner A, et al. (2005) Bacterial transfer of large functional genomic DNA into human cells. Gene Ther 12(21):1559-1572. (Pubitemid 41541774)
19. Cheung W, et al. (2012) Bacterial delivery of large intact genomic-DNA-containing BACs into mammalian cells. Bioeng Bugs 3(2):86-92.
20. Xiang S, Fruehauf J, Li CJ (2006) Short hairpin RNA-expressing bacteria elicit RNA interference in mammals. Nat Biotechnol 24(6):697-702. (Pubitemid 43882121)
21. Radford KJ, et al. (2002) A recombinant E. coli vaccine to promote MHC class I-dependent antigen presentation: Application to cancer immunotherapy. Gene Ther 9(21):1455-1463. (Pubitemid 35345574)
22. Higgins DE, Shastri N, Portnoy DA (1999) Delivery of protein to the cytosol of macrophages using Escherichia coli K-12. Mol Microbiol 31(6):1631- 1641.
23. Parsa S, Wang Y, Fuller J, Langer R, Pfeifer BA (2008) A comparison between polymeric microsphere and bacterial vectors for macrophage P388D1 gene delivery. Pharm Res 25(5):1202-1208.
24. Grillot-Courvalin C, Goussard S, Courvalin P (2002) Wild-type intracellular bacteria deliver DNA into mammalian cells. Cell Microbiol 4(3):177-186. (Pubitemid 34257734)
25. Anderson DG, Akinc A, Hossain N, Langer R (2005) Structure/property studies of polymeric gene delivery using a library of poly(β-amino esters). Mol Ther 11(3):426-434. (Pubitemid 40277319)
26. Anderson DG, Lynn DM, Langer R (2003) Semi-automated synthesis and screening of a large library of degradable cationic polymers for gene delivery. Angew Chem Int Ed Engl 42(27):3153- 3158.
27. Green JJ, Langer R, Anderson DG (2008) A combinatorial polymer library approach yields insight into nonviral gene delivery. Acc Chem Res 41(6):749-759.
28. Studier FW, Moffatt BA (1986) Use of bacteriophage T7 RNA polymerase to direct selective high-level expression of cloned genes. J Mol Biol 189(1):113-130.
29. Zugates GT, et al. (2007) Gene delivery properties of end-modified poly(β-amino ester)s. Bioconjug Chem 18(6):1887-1896. (Pubitemid 350219988)
30. Bolivar F, et al. (1977) Construction and characterization of new cloning vehicles. II. A multipurpose cloning system. Gene 2(2):95-113. (Pubitemid 9021046)
31. Doshi N, Mitragotri S (2010) Macrophages recognize size and shape of their targets. PLoS ONE 5(4):e10051.
32. Champion JA, Walker A, Mitragotri S (2008) Role of particle size in phagocytosis of polymeric microspheres. Pharm Res 25(8):1815-1821.
33. Eko FO, et al. (1999) New strategies for combination vaccines based on the extended recombinant bacterial ghost system. Vaccine 17(13-14):1643-1649. (Pubitemid 29138895)
34. Witte A, Wanner G, Sulzner M, Lubitz W (1992) Dynamics of PhiX174 protein E-mediated lysis of Escherichia coli. Arch Microbiol 157(4):381-388.
35. Daigneault M, Preston JA, Marriott HM, Whyte MK, Dockrell DH (2010) The identification of markers of macrophage differentiation in PMA-stimulated THP-1 cells and monocyte-derived macrophages. PLoS ONE 5(1):e8668.
36. Devey L, et al. (2009) Tissue-resident macrophages protect the liver from ischemia reperfusion injury via a heme oxygenase-1-dependent mechanism. Mol Ther 17(1):65-72.
37. Eltoukhy AA, et al. (2012) Effect of molecular weight of amine end-modified poly (β-amino ester)s on gene delivery efficiency and toxicity. Biomaterials 33(13):3594-3603.
38. Zugates GT, et al. (2007) Rapid optimization of gene delivery by parallel endmodification of poly(β-amino ester)s. Mol Ther 15(7):1306-1312. (Pubitemid 46965327)
39. He LZ, et al. (2007) Antigenic targeting of the human mannose receptor induces tumor immunity. J Immunol 178(10):6259-6267.
40. Keler T, He L, Graziano RF (2005) Development of antibody-targeted vaccines. Curr Opin Mol Ther 7(2):157-163. (Pubitemid 40514686)
41. He LZ, et al. (2004) A novel human cancer vaccine elicits cellular responses to the tumorassociated antigen, human chorionic gonadotropin β. Clin Cancer Res 10(6):1920-1927.